Breakdown of tolerance is a hallmark of autoimmune diseases. Over the past 10 years, there has been increased interest in the role of FoxP3 + regulatory T cells (T Regs ) in maintaining peripheral tolerance. Dysfunction of these cells is considered to play a major role in the development of autoimmune diseases. Besides their suppressive function, a fraction of these cells has the capacity to differentiate into IL-17-producing cells (Th-17), a phenomenon associated with autoimmune inflammation. The revealed plasticity of T Regs , therefore, has obvious implications when designing therapeutic strategies for restoring tolerance in autoimmune diseases using T Regs . In this review, we discuss development, classification, molecular characterization and mechanisms of suppression by T Regs . In addition, we describe recent data on their potential conversion into Th-17 cells in human systemic autoimmune diseases. We also outline a new strategy for T Reg -based therapy via isolation, expansion and re-infusion of highly pure FoxP3 + T Regs free of contaminating effector T cells.
Introduction
One of the major challenges in immunology is the understanding of cellular and molecular mechanisms involved in the discrimination between pathogens and autoantigens. Thymic clonal deletion and induction of anergy or apoptosis of self-reactive T cells upon exposure to self-antigen have been considered as major mechanisms of maintaining self-tolerance. Nevertheless, autoreactive T cells may escape these mechanisms and can be detected in the peripheral blood of most individuals [1, 2] . Autoimmunity, however, occurs in only 5% of the general population, suggesting the existence of other control mechanisms to prevent autoimmune responses.
T cells suppressing immune responses were first described in the early 1970s by Gershon and Kondo [3, 4] . In the mid-1990s, Sakaguchi et al. [5] reintroduced the paradigm of T-cell-mediated self-tolerance by identifying a subset of peripheral CD4 + T cells expressing the IL-2 receptor a-chain (CD25), which were found critical for preventing autoimmunity. They showed that CD4 + T cells depleted of CD25 + T cells from normal mice, when transferred into syngeneic athymic nude mice induced the development of multi-organ autoimmune disease in the recipients, whereas disease development was prevented by co-transfer of CD25 + CD4 + T cells together with CD25 À T cells. This observation re-evoked interest in T-suppressor cells, and defined the primary phenotype of these cells. Subsequently, in vitro studies showed that human suppressor CD4 + T cells, also termed regulatory T cells (T Regs ), constitute only those CD4 + T cells with the highest level of CD25 expression [6] . A decrease in frequency or impaired function of T Regs has been observed in several autoimmune diseases in humans, suggesting a role of these cells in the control of autoimmunity [7] . Modulation of T Reg function and number may thus present an option for immunotherapy of autoimmune diseases. Collectively, there are at least two distinct types of T Reg : the nT Regs , which are generated in the thymus upon intrathymic antigen encounter; and the iT Regs , which are generated in the periphery upon extrathymic antigen encounter. Whereas the role of iT Regs in controlling pathological immune responses has been described in mouse models, data relating to their role in human systemic autoimmune diseases are currently lacking. Therefore, we will focus on nT Regs in this review.
Molecular characterization of T Regs
A major advance in the understanding of nT Reg function was the discovery of the uniquely expressed transcription factor FoxP3, which controls the development and function of T Regs [17, 18] . The gene FoxP3, encoding the so-called scurfin protein, was first identified as a mutated gene in the scurfy mouse strain, which is an X-linked recessive mouse mutant. This mutation leads to lethality of hemizygous males 1625 days after birth in association with lymphoproliferation and multi-organ infiltration of CD4 + T cells with overproduction of cytokines by these 
Mechanisms of suppression by T Regs
Numerous in vitro studies have shown that T Regs control the expansion of naïve T cells, suppress the activation and cytokine production of effector T cells [25, 37] , and inhibit B-cell proliferation, immunoglobulin production and class switch [38, 39] . Multiple modes of action have been proposed for the suppressive function of T Regs (Fig. 1) .
Soluble factors such as IL-10 and TGF-b were found to play a key role in the suppression mediated by iT Regs . In vitro findings strongly suggest a role for these cytokines in preventing autoimmune reactions. It has been observed Thus, the production of soluble factors appears to be crucial for both iT Reg -and nT Reg -mediated suppression.
Another model of T Reg -mediated suppression suggests a cytotoxic mechanism by which T Regs induce death of effector T cells (T eff ) via release of granzymes in a perforin-and Fas-independent way [50, 51]. Accordingly, T Regs from granzyme-B-deficient mice showed a reduced capacity to suppress T eff proliferation. Otherwise, activated T Regs were recently reported to suppress B-cell proliferation in vitro by inducing apoptosis of these cells via a granzyme-B-mediated cytotoxic mechanism in a perforin-dependent way [52] . This suggests involvement of granzyme-B in a cell contact-dependent kill mechanism.
In addition to the aforementioned mechanisms, in vivo and in vitro studies have demonstrated that nT Regs can suppress the immune response by modulating the function of antigen-presenting cells (APCs). This is mediated via interaction between CTLA-4 or LAG3 (also called CD223) on nT Regs and CD80/CD86 or MHC Class II molecules on APCs, respectively. Ligation of CD80/CD86 on APC by CTLA-4 on T Regs triggers the induction of the enzyme indoleamine 2,3-dioxygenase (IDO) in APCs, which converts tryptophan into pro-apoptotic metabolites that suppress effector T cells [53] . On the other hand, engagement of MHC Class II molecules on APCs by LAG3 on T Regs suppresses APC maturation and reduces their ability to activate T cells [26, 54] . Moreover, T Regs can mediate suppression via a metabolic disruption through CD39 and CD73. These two ectoenzymes hydrolyse ATP or ADP to extracellular adenosine monophosphate, which inhibits effector T-cell functions through activating the adenosine A2A receptor [5557] .
In summary, many data have been collected on the suppressive mechanisms involved in the function of T Regs , but the precise mechanism of action of immune suppression requires further studies.
Human T Regs are not terminally differentiated but may convert to Th-17 cells
Besides the key role of T Regs in the prevention of autoimmune diseases, a recent breakthrough has revealed that IL-17-secreting cells (Th-17) are the main pathogenic effector subset involved in the induction of inflammation and autoimmunity [58, 59] . During the past 2 years, multiple reports indicate a link between T Regs and Th17 cells. It has been demonstrated that, in vitro and in vivo, activation of T cells in the presence of TGF-b results in the generation of FoxP3 + T Regs ; however, the combination of IL-6 and TGF-b promotes the generation of Th17 cells, suggesting that both T-cell subsets may differentiate from the same precursor T cell [60] . Indeed, a reciprocal relationship between T Regs and Th-17 cells has been shown recently at a molecular level [61] . It was found that full-length Foxp3 directly binds the Th-17-specific transcription factor RORgt and inhibits the expression of genes that define Th-17 cells [61] . Collectively, these findings suggest that the balance of TGF-b and IL-6 might determine the differentiation of T Reg / [86] . In view of these findings, we propose that, due to increased levels of inflammatory cytokines, T Regs are converted into effector Th-17 cells that may contribute to flares of disease activity in SLE patients. Further investigations directed at the plasticity of T Regs in SLE patients are warranted.
RA
T Regs in patients with RA appear to be present in normal numbers and to exhibit all of the features of T Regs , not only in phenotype but also in their suppression of T-cell proliferation in vitro [87, 88] . However, circulating T Regs isolated from patients with active RA are unable to suppress the release of pro-inflammatory cytokines by activated T cells and monocytes [88] . T Regs from RA patients were shown to receive increased co-stimulatory signals from activated monocytes, leading to a decrease in their suppressive capacity [89] . It has recently been demonstrated that monocytes can induce a gradual conversion of T Regs [100] . It is possible that T Regs from WG patients convert into IL-17-secreting cells in the context of an inflammatory cytokine milieu. A recent study has reported increased levels of serum IL-23 and IL-17 in WG patients [101] . In addition, expression of IL-15 has been demonstrated in areas with granuloma formation of WG patients, which may contribute to a shift of FoxP3 + T Regs into IL-17-producing cells [102] . More importantly, we demonstrated an increase in the percentage of Th-17 cells in WG patients as compared with healthy controls [103] . These data favour the conversion of T Regs towards IL-17-producing T cells in WG patients. Therefore, 
SS
SS is an autoimmune exocrinopathy, characterized by chronic inflammation and destruction of the lacrimal and salivary glands resulting in dryness of the eyes (KCS) and mouth (xerostomia) [104] . Similar to other autoimmune diseases, impairment in number or function of T Regs could be involved in the development and perpetuation of SS. However, studies on T Regs in SS patients have yielded controversial results. Gottenberg et al. [105] were positively correlated with the focus scores in the salivary gland biopsy, which suggests an association of infiltrated T Regs with the grade of severity of the autoimmune lesion in SS patients [108] . Moreover, increase in IL-15 expression was observed in biopsies from SS patients with ectopic germinal centre formation [109] . Furthermore, infiltrating CD4 + T cells in the salivary glands of SS patients predominantly expressed IL-17 [110, 111] . In addition, expression levels of IL-17 in the salivary glands progressively increased with higher levels of focus scores [112] , as did numbers of FoxP3 + T Reg cells [108] . These data suggest that the inflammatory cytokine milieu within the lesions promotes the conversion of infiltrated FoxP3 + T Regs into IL-17-producing cells that may underlie the development of lymphocyte infiltrates in SS.
Strategy for expansion and isolation of highly pure FoxP3 + T Regs to be used in cellular therapy Similar to the aforementioned approach, we propose a two-step, new strategy for adoptive T Reg -based forms of therapy (Fig. 3) . In this two-step approach, we first seek to expand the number of T cells (and thus also the nT Regs ), and secondly to isolate pure T Regs via negative selection. To this end, peripheral blood mononuclear cells are isolated from a patient, and stimulated polyclonally with anti-CD3 and anti-CD28 monoclonal antibodies for 7 days in the presence of IL-1b, IL-2, IL-6, IL-15 and IL-23. In this culture condition, numbers of T Regs will increase, and a fraction of FoxP3 + T cells will differentiate towards IL-17-producing cells. The fraction of FoxP3 + T Reg cells that does not produce IL-17 (or does not convert into Th-17 cells) is characterized by lack of surface expression of CD49d and CD127 [113] . The latter fraction of T Regs can be isolated negatively by two steps using immunomagnetic beads technique (Fig. 3) and CD127) will be collected, and finally re-injected into the patients in order to restore the T Reg /T-effector balance in autoimmune diseases. It was previously shown that epigenetic modification underlies the phenomenon of T Reg plasticity [62] . Thus, it is feasible that concomitant treatment with histone deacetylase inhibitors may help stabilize the T Reg phenotype and may thus add to the success of cellular T Reg therapy. Clearly, further clinical studies aimed at optimizing this approach for treating human systemic autoimmune diseases are warranted.
Summary
Major focus has been placed on the role of + T cells will be isolated by negative selection using an immunomagnetic beads technique. Subsequently, CD4 + T cells will be stained for bead-conjugated anti-CD49d and anti-CD127. In this step, the cells double positive for CD49d and CD127 (which are the IL-17-producing cells) will be removed, and highly purified FoxP3 + T Regs will thus be isolated by negative selection (being double negative for CD49d and CD127 
